Quality Control News and Research

RSS

InComm, Pursuant Health partner to promote health risk assessments in Walmart stores

InComm, a leading prepaid product and transaction services company, and Pursuant Health (formerly SoloHealth) announced today a partnership to allow health plans to promote health risk assessments (HRAs) at Pursuant Health kiosks in Walmart stores. Health plans will be able to issue their members branded incentive cards with healthy rewards as part of the completion of the HRA.

27 Oct 2015

SKYSCAN 1275 provides high quality 3D images by highly automated, self optimizing, micro-CT

With the introduction of the new SKYSCAN™ 1275 highly automated, self-optimizing desktop X-ray microtomograph, Bruker puts class-leading imaging into the hands of materials and life scientists in both research and industrial applications, such as high-throughput 3D imaging in quality control and production process monitoring.

From Bruker BioSpin - NMR, EPR and Imaging 26 Oct 2015

Ortho Clinical Diagnostics’ ORTHO VISION Max blood analyzer receives CE Mark clearance

Ortho Clinical Diagnostics today announced ORTHO VISION™ Max, a fully automated blood analyser for high-volume transfusion medicine laboratories, received CE Mark clearance, signifying its conformity with all EU regulation. It will be available for purchase in Europe and Japan in October.

22 Oct 2015

RUCDR Infinite Biologics awarded $6 million grant from NINDS

The National Institute of Neurological Disorders and Stroke has awarded a five-year grant worth up to $6,034,323 to RUCDR Infinite Biologics, a unit of Rutgers' Human Genetics Institute of New Jersey. RUCDR, which is located on Rutgers' Busch Campus in Piscataway, is the world's largest university-based biorepository.

20 Oct 2015

Immatics, UTHealth to partner on cellular manufacturing for adoptive cellular therapy clinical trials

Immatics US, Inc., a subsidiary of Immatics Biotechnologies GmbH, and The University of Texas Health Science Center at Houston will collaborate on cellular manufacturing for adoptive cellular therapy (ACT) clinical trials.

19 Oct 2015

US and German researchers team up to advance quality control of human stem cells

Researchers at The Scripps Research Institute (TSRI) in California, USA, and two German institutes, the Center for Integrated Psychiatry Kiel (ZIP) and the Fraunhofer Institute for Molecular Biology and Applied Ecology IME, have announced a partnership to advance the quality control of human stem cells.

16 Oct 2015

UCLA Health adopts GenomOncology's GO Clinical Workbench to accelerate analysis for tumor DNA profiling tests

GenomOncology today announced that UCLA Health has adopted the GO Clinical Workbench to accelerate analysis and reporting for its tumor DNA profiling tests.

13 Oct 2015

NHS should remove unproven apps from library, say experts

There is no proof that 85% of the depression apps currently recommended by the NHS for patients to manage their condition actually work, say experts in the journal Evidence Based Mental Health.

13 Oct 2015

Myriad Genetics and Tufts Health Plan sign agreement to cover Prolaris® for members with localized prostate cancer

Myriad Genetics, Inc. (NASDAQ: MYGN) has announced that it has signed a three-year contract with Tufts Health Plan through which the plan will provide coverage of Prolaris® for members diagnosed with localized prostate cancer. Prolaris is the first and only biopsy test validated against prostate cancer specific mortality.

7 Oct 2015

WuXi NextCODE, Sidra partner to provide comprehensive research and bioinformatics programs in Qatar

WuXi NextCODE, a precision medicine company using the genome to improve health worldwide, and Sidra Medical and Research Center, a groundbreaking hospital, research and education institution, today announced a broad, long-term agreement to provide and co-develop comprehensive research and bioinformatics programs.

6 Oct 2015

Beckman Coulter Life Sciences launches QbD1200 Total Organic Carbon (TOC) Analyzer

Beckman Coulter Life Sciences has launched the QbD1200 Total Organic Carbon (TOC) Analyzer.

From Beckman Coulter Life Sciences - Particle Counting and Characterization 1 Oct 2015

Coalition unions, Kaiser Permanente sign landmark contract to protect health care workers and patients from flu

A coalition of unions representing Kaiser Permanente health care workers in the nation's largest private sector talks this year have ratified a landmark agreement that includes a jointly developed flu vaccination policy for health care workers who deal directly with patients.

30 Sep 2015

Catasys starts enrolling members in OnTrak Program

Catasys, Inc., a provider of proprietary big data based analytics and predictive modeling driven behavioral health management services for health plans, announced today that it has begun enrolling members in its OnTrak Program with Health Alliance Medical Plans (Health Alliance) in Illinois. In April, Catasys and Health Alliance announced a multi-year agreement for the OnTrak Program.

30 Sep 2015

Duke Raleigh Hospital becomes first healthcare facility to use certified mobile compounding cleanroom

Duke Raleigh Hospital recently became the first healthcare facility to utilize a certified USP 797 mobile cleanroom to assure uninterrupted pharmacy services. The advanced pharmacy unit, created by Germfree Labs, allowed the hospital to maintain separate, on-site sterile drug compounding operations during a major renovation project.

24 Sep 2015

Novel graphene oxide-based biosensor may speed up development of new drugs against HIV, cancer

Longing to find a cure for cancer, HIV and other yet incurable diseases, researchers have already tried out hundreds of drugs, each requiring preclinical and clinical testing with live subjects. How many chemical agents more to try? Moving at such rate, will we find the cure during our lifetime? One of the easiest ways to speed up the drug development process is to simply perform it outside of the living body (e.g., by watching the substances react with the smallest pieces of live tissue and thus quickly predicting the overall effect it will make to the body when inside).

23 Sep 2015

Caring for women who develop invasive breast tumor in Germany

Every year, more than 70 000 women in Germany develop an invasive breast tumor. This makes breast cancer the most common tumor disease in women. The current edition of Deutsches Ärzteblatt International (Edition 35/36) contains no less than three articles focusing on breast cancer.

22 Sep 2015

Pipetting Solutions for Sample Screening

Our research focuses on interleukin 1 and the inflammasome and their role in innate immunity and inflammation.

From INTEGRA Biosciences 16 Sep 2015

Benefits of reagent reservoirs video

A new short and engaging SimpleShow’ format video from INTEGRA introduces and explains the unique features and benefits of their Multichannel Pipette Reagent Reservoirs.

From INTEGRA Biosciences 16 Sep 2015

EORTC and ESSO project provides opportunity to do prospective study on liver metastasis surgery

Is it possible to cure patients with unresectable colorectal liver metastases? Are complex surgeries safe for patients with extensive metastatic disease? How can we monitor and improve the quality of these surgical strategies? How can we improve surgical care for patients through research?

15 Sep 2015

Cynosure obtains European MDD certification for SculpSure

Cynosure, Inc., a leader in laser- and light-based aesthetic treatments, today announced that it has received European Medical Device Directive (MDD) certification from its European Notified Body for SculpSure, the world's first hyperthermic aesthetic laser for non-invasive fat reduction. The certification, from Intertek Semko AB, allows Cynosure to place the "CE" Mark on SculpSure for distribution in the European Union and its member states.

10 Sep 2015